URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

J. Steven Lamberti

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentPsychiatry
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box PSYCH
Rochester NY 14642
 
 Awards And Honors
1979     Summa Cum Laude, University of Missouri
1987     Richard F. Jaenike Award for Outstanding Performance in Clinical Psychiatry, URMC Department of Psychiatry
1996     Otto F. Thaler Teaching Award, URMC Department of Psychiatry
1996     East House Corporation Partners in Quality Award
1996 - 2009Best Doctors in America  | America's Best Doctors
1997     Residents Recognition Award, URMC Department of Psychiatry
1998     Schizophrenia Reintegration Award  | Eli Lilly and Company
1998     Compeer Community Service Awards
1999     Services Achievement Gold Award  | American Psychiatric Association
2000     Fellow in Psychiatry  | American Psychiatric Association
2002     Community Health Improvement Award, Healthcare Association of New York State, Strong Memorial Hospital
2003     Distinguished Fellow in Psychiatry  | American Psychiatric Association
2004     Van Ameringen Award for Psychiatric Rehabilitation  | American Psychiatric Association
2005     Margaret Van Horn Award for Distinguished Service in Psychiatry  | University of Medicine and Densistry of New Jersey
2007     CARES Appreciation Award  | Committee to Aid Research to End Schizophrenia
2009     NAMI New York State Recognition Award  | National Alliance on Mental Illness
2010     Sidney J. Rubin Award for Teaching Excellence  | URMC Department of Psychiatry
 
 Selected Publications
  • Lamberti JS, Deem A, Weisman RL, LaDuke C. The role of probation in forensic assertive community treatment. Psychiatr Serv. 2011 Apr; 62(4):418-21.
    View in: PubMed
  • Punn R, Lamberti JJ, Balise RR, Seslar SP. QTc prolongation in children following congenital cardiac disease surgery. Cardiol Young. 2011 Aug; 21(4):400-10.
    View in: PubMed
  • Mallinger JB, Lamberti JS. Psychiatrists' attitudes toward and awareness about racial disparities in mental health care. Psychiatr Serv. 2010 Feb; 61(2):173-9.
    View in: PubMed
  • Ran MS, Chen PY, Liao ZG, Chan CL, Chen EY, Tang CP, Mao WJ, Lamberti JS, Conwell Y. Criminal behavior among persons with schizophrenia in rural China. Schizophr Res. 2010 Sep; 122(1-3):213-8.
    View in: PubMed
  • Lamberti JS. Letter to the editor. Psychiatr Rehabil J. 2010; 34(2):89-90; author reply 91-2.
    View in: PubMed
  • Erickson SK, Lamberti JS, Weisman R, Crilly J, Nihalani N, Stefanovics E, Desai R. Predictors of arrest during forensic assertive community treatment. Psychiatr Serv. 2009 Jun; 60(6):834-7.
    View in: PubMed
  • Crilly JF, Caine ED, Lamberti JS, Brown T, Friedman B. Mental health services use and symptom prevalence in a cohort of adults on probation. Psychiatr Serv. 2009 Apr; 60(4):542-4.
    View in: PubMed
  • Lamberti JS. Revisiting the MacArthur study. Psychiatr Serv. 2008 Apr; 59(4):445; author reply 445-6.
    View in: PubMed
  • Kim SY, Appelbaum PS, Swan J, Stroup TS, McEvoy JP, Goff DC, Jeste DV, Lamberti JS, Leibovici A, Caine ED. Determining when impairment constitutes incapacity for informed consent in schizophrenia research. Br J Psychiatry. 2007 Jul; 191:38-43.
    View in: PubMed
  • Lamberti JS. Understanding and preventing criminal recidivism among adults with psychotic disorders. Psychiatr Serv. 2007 Jun; 58(6):773-81.
    View in: PubMed
  • Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008 Feb; 33(3):465-72.
    View in: PubMed
  • Nihalani ND, Tu X, Lamberti JS, Olson D, Olivares T, Costea GO, Tang W. Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors. Ann Clin Psychiatry. 2007 Apr-Jun; 19(2):105-12.
    View in: PubMed
  • Spurling RD, Lamberti JS, Olsen D, Tu X, Tang W. Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review. J Clin Psychiatry. 2007 Mar; 68(3):406-9.
    View in: PubMed
  • Erickson SK, Ciccone JR, Schwarzkopf SB, Lamberti JS, Vitacco MJ. Legal fallacies of antipsychotic drugs. J Am Acad Psychiatry Law. 2007; 35(2):235-46.
    View in: PubMed
  • Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, Tang W, Wiener K, Dvorin S, Dietz MB. Prevalence of the metabolic syndrome among patients receiving clozapine. Am J Psychiatry. 2006 Jul; 163(7):1273-6.
    View in: PubMed
  • Nihalani ND, Kunwar A, Staller J, Lamberti JS. How should psychiatrists dress?--a survey. Community Ment Health J. 2006 Jun; 42(3):291-302.
    View in: PubMed
  • Mallinger JB, Lamberti JS. Clozapine--should race affect prescribing guidelines? Schizophr Res. 2006 Mar; 83(1):107-8.
    View in: PubMed
  • Mallinger JB, Fisher SG, Brown T, Lamberti JS. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatr Serv. 2006 Jan; 57(1):133-6.
    View in: PubMed
  • Lamberti JS, Costea GO, Olson D, Crilly JF, Maharaj K, Tu X, Groman A, Dietz MB, Bushey MP, Olivares T, Wiener K. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates. J Clin Psychiatry. 2005 Jul; 66(7):900-6.
    View in: PubMed
  • Lamberti JS, Weisman R, Faden DI. Forensic assertive community treatment: preventing incarceration of adults with severe mental illness. Psychiatr Serv. 2004 Nov; 55(11):1285-93.
    View in: PubMed
  • Ran MS, Xiang MZ, Conwell Y, Lamberti JS, Huang MS, Shan YH, Hu XZ. Comparison of characteristics between geriatric and younger subjects with schizophrenia in community. J Psychiatr Res. 2004 Jul-Aug; 38(4):417-24.
    View in: PubMed
  • Lamberti JS, Crilly JF, Maharaj K, Olson D, Wiener K, Dvorin S, Costea GO, Bushey MP, Dietz MB. Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs. J Clin Psychiatry. 2004 May; 65(5):702-6.
    View in: PubMed
  • Weisman RL, Lamberti JS, Price N. Integrating criminal justice, community healthcare, and support services for adults with severe mental disorders. Psychiatr Q. 2004; 75(1):71-85.
    View in: PubMed
  • Lamberti JS, Weisman RL. Persons with severe mental disorders in the criminal justice system: challenges and opportunities. Psychiatr Q. 2004; 75(2):151-64.
    View in: PubMed
  • Weisman RL, Lamberti JS. Violence prevention and safety training for case management services. Community Ment Health J. 2002 Aug; 38(4):339-48.
    View in: PubMed
  • Lamberti JS. Seven keys to relapse prevention in schizophrenia. J Psychiatr Pract. 2001 Jul; 7(4):253-9.
    View in: PubMed
  • Seger A, Lamberti JS. Priapism associated with polypharmacy. J Clin Psychiatry. 2001 Feb; 62(2):128.
    View in: PubMed
  • Lamberti JS, Weisman RL, Schwarzkopf SB, Price N, Ashton RM, Trompeter J. The mentally ill in jails and prisons: towards an integrated model of prevention. Psychiatr Q. 2001; 72(1):63-77.
    View in: PubMed
  • Lamberti JS. Is antipsychotic drug--induced weight gain associated with a favorable clinical response? J Clin Psychiatry. 2000 Sep; 61(9):678.
    View in: PubMed
  • Herz MI, Lamberti JS, Mintz J, Scott R, O'Dell SP, McCartan L, Nix G. A program for relapse prevention in schizophrenia: a controlled study. Arch Gen Psychiatry. 2000 Mar; 57(3):277-83.
    View in: PubMed
  • Lamberti JS, Melburg V, Madi N. Intensive Psychiatric Rehabilitation Treatment (IPRT): an overview of a new program. Psychiatr Q. 1998; 69(3):211-34.
    View in: PubMed
  • Lamberti JS, Bellnier TJ, Schwarzkopf SB, Schneider E. Filgrastim treatment of three patients with clozapine-induced agranulocytosis. J Clin Psychiatry. 1995 Jun; 56(6):256-9.
    View in: PubMed
  • Herz MI, Lamberti JS. Prodromal symptoms and relapse prevention in schizophrenia. Schizophr Bull. 1995; 21(4):541-51.
    View in: PubMed
  • Lamberti JS, Schwarzkopf SB, Boutros N, Crilly JF, Martin R. Within-session changes in sensory gating assessed by P50 evoked potentials in normal subjects. Prog Neuropsychopharmacol Biol Psychiatry. 1993 Sep; 17(5):781-91.
    View in: PubMed
  • Wiener K, Lamberti JS. Sertraline and mental retardation with obsessive-compulsive disorder. Am J Psychiatry. 1993 Aug; 150(8):1270.
    View in: PubMed
  • Schwarzkopf SB, Lamberti JS, Smith DA. Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry. 1993 Jun 1-15; 33(11-12):815-28.
    View in: PubMed
  • Privitera MR, Lamberti JS, Maharaj K. Clozapine in a bipolar depressed patient. Am J Psychiatry. 1993 Jun; 150(6):986.
    View in: PubMed
  • Lamberti JS, Bellnier T. Clozapine and tardive dystonia. J Nerv Ment Dis. 1993 Feb; 181(2):137-8.
    View in: PubMed
  • Lamberti JS, Bellnier T, Schwarzkopf SB. Weight gain among schizophrenic patients treated with clozapine. Am J Psychiatry. 1992 May; 149(5):689-90.
    View in: PubMed
  • Lamberti JS, Cummings S. Hands-on restraints in the treatment of multiple personality disorder. Hosp Community Psychiatry. 1992 Mar; 43(3):283-4.
    View in: PubMed
  • Schwarzkopf SB, Lamberti JS, Jiminez M, Kane CF, Henricks M, Nasrallah HA. Visual evoked potential correlates of positive/negative symptoms in schizophrenia. Biol Psychiatry. 1990 Feb 15; 27(4):400-10.
    View in: PubMed
  • Schwarzkopf SB, Chapman RM, Jimenez M, Treglia L, Kane CF, Lamberti JS, Nasrallah HA. Familial and sporadic schizophrenia: visual evoked potential differences. Biol Psychiatry. 1988 Nov; 24(7):828-33.
    View in: PubMed

Visualizations


Lamberti's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department